»search site
The International Academy of Cardiology is dedicated to Cardiology Online - International Academy of Cardiologythe advancement of global research in cardiovascular medicine through the support of scientific meetings and publications.
   Home Page
   Discussion Groups
   Job Opportunities
   Contact Us





21st World Congress on Heart Disease



Shahbudin H. Rahimtoola, M.D., University of Southern California, Los Angeles, CA, USA


VP- PM was first described in 1978 by Rahimtoola. From that time to 2011, aortic VP-PM has received a great deal of attention but studies have come to varying conclusions especially with regard to its effect on mortality. This is because prosthetic heart valve (PHV) area [effective orifice area index (EOAi)] has been predicted rather than measured. To better assess the outcomes of VP-PM, EOAi should be measured at hospital discharge which provides information of actual PHV after insertion into the patient. It should also be measured at 6-12 months of follow-up at which time the 4 phases of physiological healing and morphological changes are complete; EOAi at this time determines the long-term impact of VP-PM on patientsí outcomes. Mild, severe and critical VP-PM should be defined as EOAi of = 0.9 cm2/m2, EOAi of = 0.6 cm2/m2 and EOAi of = 0.4 cm2/m2. One needs to focus especially on severe/critical degrees of VP-PM and determine if death was actually due to VP-PM and/or was VP-PM an important determinant of cardiac related cause of death by multivariate analysis?



©1998-2017 Cardiology Online, Inc. All rights reserved.
Cardiology Online is a registered trademark of Cardiology Online, Inc.